In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
about
The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosisRedox mechanisms in age-related lung fibrosisRole of endoplasmic reticulum stress in drug-induced toxicityPharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineThe mitochondrial cardiolipin remodeling enzyme lysocardiolipin acyltransferase is a novel target in pulmonary fibrosis.The role of catalase in pulmonary fibrosis.The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.Role of glutathione in lung retention of 99mTc-hexamethylpropyleneamine oxime in two unique rat models of hyperoxic lung injuryAndrographolide plays an important role in bleomycin-induced pulmonary fibrosis treatment.Molecular and cellular mechanisms of pulmonary fibrosis.Role of matrix metalloproteinases in the development of airway inflammation and remodeling.The Chinese Herbal Medicine Formula mKG Suppresses Pulmonary Fibrosis of Mice Induced by Bleomycin.The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?Antioxidants as potential therapeutics for lung fibrosis.Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression.Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosisEvaluating the Ameliorative Potential of Quercetin against the Bleomycin-Induced Pulmonary Fibrosis in Wistar Rats.Bach1 siRNA attenuates bleomycin-induced pulmonary fibrosis by modulating oxidative stress in mice.Thiol-redox antioxidants protect against lung vascular endothelial cytoskeletal alterations caused by pulmonary fibrosis inducer, bleomycin: comparison between classical thiol-protectant, N-acetyl-L-cysteine, and novel thiol antioxidant, N,N'-bis-2-Cellular and Molecular Mediators of Intestinal Fibrosis.N-acetylcysteine amide, a thiol antioxidant, prevents bleomycin-induced toxicity in human alveolar basal epithelial cells (A549).Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis.Triptolide mitigates radiation-induced pneumonitis via inhibition of alveolar macrophages and related inflammatory molecules.A small molecule, orally active, alpha4beta1/alpha4beta7 dual antagonist reduces leukocyte infiltration and airway hyper-responsiveness in an experimental model of allergic asthma in Brown Norway rats.Sulfasalazine-induced renal and hepatic injury in rats and the protective role of taurine.Cellular and molecular mechanisms of intestinal fibrosis.Assessment of lung toxicity caused by bleomycin and amiodarone by Tc-99m HMPAO lung scintigraphy in rats.Therapeutic effect of lecithinized superoxide dismutase on bleomycin-induced pulmonary fibrosis.Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression.Expression of heme oxygenase-1 in the lungs of rats exposed to crocidolite asbestos.Nickle(II) ions exacerbate bleomycin-induced pulmonary inflammation and fibrosis by activating the ROS/Akt signaling pathway.Systemic inflammation and oxidative stress post-lung resection: Effect of pretreatment with N-acetylcysteine.Mouse models of bleomycin-induced pulmonary fibrosis.Aliskiren attenuates bleomycin-induced pulmonary fibrosis in rats: focus on oxidative stress, advanced glycation end products, and matrix metalloproteinase-9.A Potential Link Between Oxidative Stress and Endothelial-to-Mesenchymal Transition in Systemic SclerosisNo Perioperative Pulmonary Complications after Restricted Oxygen Exposition in Bleomycin-Treated Patients: A Short Report
P2860
Q24803487-8E9A99E9-C38D-4E0E-A515-1D59F7FF2EDEQ26743421-A178E33D-D624-459A-BFA0-36408D7BD461Q26765518-6B8D00D5-5728-420E-A57F-48708B1899F9Q26777928-22FD7BF0-B7E9-4AE7-9467-9FA8BB2913A5Q33901590-0EA8C2A2-9954-4980-B10E-763F7751D620Q34499311-D9020637-17DC-4BBD-A740-76769C21545FQ34811358-3D3C08D7-2A7E-4CDC-8DD0-7466D6CEB7ACQ36128020-31F0C437-9483-4910-900C-722D468D70CEQ36178766-72ED804A-7867-45E0-8D0F-2112F76DCF1EQ36182707-C59E008B-809D-4F76-A4E5-F262E9CB5E94Q36237168-2241DB38-4AFF-458A-8555-7F5866675D68Q36261727-44C8D218-0870-46C9-BDE0-9F9E7627EEE0Q36667164-E7595B7C-5884-4BB4-8391-D798B6B44C36Q36970923-D5DD76E2-1423-4410-88EF-B8FD7A14119CQ36999926-E52671E2-2D6E-4AA0-B4B3-467F06B85215Q37064722-34ADE784-6935-4B06-B2FB-BFA870F0B519Q37086303-A201D885-2951-4720-8A2E-845EF88F7346Q37419128-014A99DC-4490-4A12-85BD-163BA3FC55A7Q37527828-8654D5A5-A063-4588-ADE3-9511FDB6A65DQ37557245-323EB65D-1175-4C2C-92D9-2479BBD1B3D0Q38259227-6B47C4B4-2AD1-4C11-A5DB-237E2BD54784Q39134299-668B8EC0-E537-4360-9E42-B9D5B259C85BQ40191474-C142D2CB-E95A-4D9A-94D6-137B35C620E3Q41233182-8E1EA979-177B-4C74-9CFA-36C6C391AA11Q42108571-A01AF81A-4A8B-46DF-B464-84CBD22E5DD6Q42183819-58896BB4-45DA-4640-B038-88C3FD71BE13Q42252132-A389B38C-4399-4F47-8251-6C304E1B7EE7Q42263515-449936B2-6601-4736-8141-2145D3AE5F6BQ43207795-D54FA137-1292-45D7-8FC0-3E8586BFF294Q43261580-642BE8CA-11F7-4D90-A763-03CE1CEAFF9DQ46425652-9FD6DC95-6DE3-4B7F-8E60-C4994999A09EQ47353514-ECFEB050-B094-4E18-A691-0BF7AB9D5735Q50280130-4FB0AAB9-82E9-444B-8A89-8CF51B94EF4FQ50657931-5E126269-CA30-42A3-884E-4F5D6F35FDD5Q53763737-CE027448-CC88-4E6B-BBB9-57543DF39AA8Q57072741-E3C8C387-5768-4171-AFBE-23BD2BDDFB65Q58688738-1C578991-5AC3-409B-8EBF-02A97BEAD0A4
P2860
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@en
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@nl
type
label
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@en
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@nl
prefLabel
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@en
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@nl
P2093
P2860
P356
P1476
In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
@en
P2093
A Serrano-Mollar
E J Morcillo
J M Estrela
M Martinez-Losa
P2860
P304
P356
10.1038/SJ.BJP.0705138
P407
P577
2003-03-01T00:00:00Z